Podoplanin as a biomarker and chemotherapeutic target for oral squamous cell carcinoma

被引：0
|
作者：
Retzbach, Edward P. [1 ]
Kato, Yukinari [2 ]
Goldberg, Gary S. [1 ]
机构：
[1] Rowan Univ, Sch Osteopath Med, Glassboro, NJ USA
[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
PDPN; Oral cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1295
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [1] Utilization of podoplanin as a chemotherapeutic target for oral squamous cell carcinoma
    Retzbach, Edward P.
    Krishnan, Harini
    Ochoa-Alvarez, Jhon A.
    Shen, Yongquan
    Nevel, Evan
    Kephart, David J.
    Kalyoussef, Evelyne
    Baredes, Soly
    Fatahzadeh, Mahnaz
    Rameriz, Maria I.
    Yin, Kingsley
    Young, Mary Ann
    Deluca-Rapone, Lisa
    Shienbaum, Alan J.
    Jensen, Lasse D.
    Goldberg, Gary S.
    CANCER RESEARCH, 2016, 76
  • [2] Podoplanin's diverse potential as a chemotherapeutic target for oral squamous cell carcinom
    Retzbach, Edward P.
    Krishnan, Harini
    Ochoa-Alvarez, Jhon A.
    Shen, Yongquan
    Nevel, Evan
    Kephart, David J.
    Kalyoussef, Evelyne
    Baredes, Soly
    Fatahzadeh, Mahnaz
    Yin, Kingsley
    Shienbaum, Alan J.
    Kato, Yukinari
    Jensen, Lasse
    Goldberg, Gary S.
    CANCER RESEARCH, 2017, 77
  • [3] Podoplanin (PDPN): novel biomarker and chemotherapeutic target
    Krishnan, Harini
    Ochoa-alvarez, Jhon
    Shen, Yongquan
    Nevei, Evan
    Kephart, David
    Nguyen, Angels
    Han, Min
    Acharya, Nimish
    Nagele, Robert
    Ramirez, Maria
    Miller, W. Todd
    Kalyoussef, Evelyne
    Baredes, Soly
    Fatahzadeh, Mahnaz
    Jensen, Lasse
    Shienbaum, Alan
    Goldberg, Gary
    CANCER RESEARCH, 2015, 75
  • [4] Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
    Patil, Ashok
    Patil, Kishor
    Tupsakhare, Suyog
    Gabhane, Mahesh
    Sonune, Shrikant
    Kandalgaonkar, Shilpa
    SCIENTIFICA, 2015, 2015
  • [5] Expression of podoplanin in different grades of oral squamous cell carcinoma
    Prasad, B.
    Kashyap, B.
    Babu, G. S.
    Kumar, G. R.
    Manyam, R.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2015, 5 (04) : 299 - 304
  • [6] Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms
    Ochoa-Alvarez, Jhon A.
    Krishnan, Harini
    Pastorino, John G.
    Nevel, Evan
    Kephart, David
    Lee, Joseph J.
    Retzbach, Edward P.
    Shen, Yongquan
    Fatahzadeh, Mahnaz
    Baredes, Soly
    Kalyoussef, Evelyne
    Honma, Masaru
    Adelson, Martin E.
    Kaneko, Mika K.
    Kato, Yukinari
    Young, Mary Ann
    Deluca-Rapone, Lisa
    Shienbaum, Alan J.
    Yin, Kingsley
    Jensen, Lasse D.
    Goldberg, Gary S.
    ONCOTARGET, 2015, 6 (11) : 9045 - 9060
  • [7] Podoplanin expression in various types of oral dysplasia and oral squamous cell carcinoma
    Mashhadiabbas, Fatemeh
    Chafjiri, Maryam M.
    Dashti, Mahmood
    Mudasser, Muhammad A.
    Gholami, Sanaz
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2025, 20 (01): : 40 - 51
  • [8] Expression of endoglin and podoplanin in early and advanced oral squamous cell carcinoma
    Lee, Sang-Woon
    Park, Young-Wook
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2012, 38 (03) : 145 - 151
  • [9] A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
    Srinivasan, Vaishnavi
    Shyam, N. D. V. N.
    Kumar, G. Kiran
    Narayen, Vaishali
    Konda, Paremala
    Rani, Korra Swetha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [10] Clinical implications of podoplanin and plasma soluble podoplanin in early-stage oral squamous cell carcinoma
    Kawaguchi, Sho
    Kawahara, Kenta
    Sakata, Junki
    Hirosue, Akiyuki
    Yoshida, Ryoji
    Matsuoka, Yuichiro
    Arita, Hidetaka
    Nakashima, Hikaru
    Gohara, Shunsuke
    Yamana, Keisuke
    Nagao, Yuka
    Hiraki, Akimitsu
    Nakayama, Hideki
    CANCER SCIENCE, 2018, 109 : 500 - 500
12345